tiprankstipranks
Trending News
More News >
Insight Molecular Diagnostics (IMDX)
NASDAQ:IMDX
US Market
Advertisement

Insight Molecular Diagnostics (IMDX) Balance Sheet

Compare
427 Followers

Insight Molecular Diagnostics Balance Sheet

Insight Molecular Diagnostics's total assets for Q2 2025 were $50.52M, a decrease of -16.31% from the previous quarter. IMDX total liabilities were $49.42M for the fiscal quarter, a -1.44% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Assets
$ 35.08M$ 74.89M$ 100.09M$ 159.56M$ 55.42M
Total Liabilities
$ 47.35M$ 49.30M$ 65.80M$ 94.35M$ 21.94M
Total Equity Gross Minority
$ -12.27M$ 25.59M$ 34.29M$ 65.22M$ 33.48M
Other Metrics
Currency in USD

Insight Molecular Diagnostics Debt to Assets

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis